Navigation Links
New research on sexual function
Date:8/19/2008

LINTHICUM, MD, August 18, 2008Young researchers presented innovative, early-stage research at the 16th Annual Summer Research Conference, a collaborative project of the AUA Foundation and the Society for Basic Urologic Research (SBUR), on August 7-9, 2008. The AUA Foundation hosted the forum for young investigators to showcase and discuss the most cutting-edge research in sexual medicine. These investigators represent the future of sexual medicine research and their contributions to the field will likely change how sexual dysfunction will be diagnosed and treated in the future.

The following notable findings were presented at the conference:

Metabolic syndrome can impact erectile function. Researchers tested the theory that statins might improve sexual function in men with metabolic syndrome. Researchers injected statins three times a day into 16-20 week old rats for five days. The statins alleviated vascular constriction associated with metabolic syndrome and improved erectile function.

Reversal of Voltage-Dependent Erectile Responses in the Obese-Zucker Rat by Statins was Mediated by Alteration in Rho/ Rho‐kinase Signaling
Christopher Wingard, PhD

Convention dictates depriving hypogonadal men of testosterone after a radical prostatectomy to avoid the possibility of feeding any remaining cancerous cells. However, researchers argue that androgen therapy may actually restore sexual function faster post-prostatectomy than androgen deprivation with (PDE ) 5 inhibitors. New studies are underway to test this theory.

Androgens and Sexual Function.
Mohit Khera, MD, MBA

While most studies group diabetic subjects into one cohort, Chitaley's study separated mice into type I and type II diabetes categories. Separating diabetic mice into separate cohorts showed that unique dysfunctions are at the root of erectile dysfunction in type I vs. type II diabetic mice. Future treatment of diabetes-rela
'/>"/>

Contact: Lacey Holt
lholt@AUAnet.org
401-689-4054
American Urological Association
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Make an Impact on Pediatric Cancer Research Before Summers End: Try Some Virtual Lemonade!
2. New method to overcome multiple drug resistant diseases developed by Stanford researchers
3. Medco Announces Research Collaboration with FDA Focused on Personalized Medicine
4. SAGE to publish Journal of Dental Research beginning in 2009
5. Dunkin Donuts Event Raises $800,000 for Cancer Research in One Day
6. Researchers Examine Safety of Internet Prescriber Service Providing Erectile Dysfunction Medications
7. Researchers examine safety of Internet prescriber service providing erectile dysfunction medications
8. Tiny molecule helps control blood-vessel development, UT Southwestern researchers find
9. ABC Releases Monograph on Scientific Research of POM Wonderful(R) Pomegranate Juice
10. Morris Animal Foundation Receives $1 Million Donation From Hills for Cat Health Research - Cat Lovers Have Reason to Celebrate
11. DIA Innovation Forum to Highlight Latest Initiatives in Research & Development in the EU
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... million older Americans suffer from depression, often brought on ... research a project that followed the lives of ... found that Internet use among the elderly can reduce ... , "That,s a very strong effect," said Shelia Cotten, ... and media who led the project. "And it all ...
(Date:4/17/2014)... about one in five infants in the United States ... first several months after birth. Research into probiotic use ... the April 1, 2014 issue of the British ... study, "Probiotics and Infant Colic," concluding that the use ... colic did not reduce crying or fussing in ...
(Date:4/17/2014)... (BUSM) have discovered that the anti-seizure drug ezogabine, ... findings, reported in the American Journal of ... more effective treatments for alcoholism. , Excessive consumption ... of illness and death in the U.S. and ... productivity of workers and necessitating huge health care ...
(Date:4/17/2014)... researchers at UC Davis has shown that the cyclin ... cell division, also boosts the mitochondrial activity to power ... has been shown to perform both jobs. This newfound ... control cellular energy production, potentially advancing cancer care and ... the journal Developmental Cell . , "These proteins ...
(Date:4/17/2014)... team led by Cesar A. Arias, M.D., Ph.D., at ... (UTHealth) has identified a new superbug that caused a ... in the April 17 issue of The New ... is part of a class of highly-resistant bacteria known ... is a major cause of hospital and community-associated infections. ...
Breaking Medicine News(10 mins):Health News:Internet use can help ward off depression among elderly 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:New MRSA superbug emerges in Brazil 2
... Medic, the Mecklenburg EMS,Agency, has fully ... Center, which will offer the most-advanced and,challenging ... emergency,medical services personnel. Using interactive robotic ... scene and situation, trainees face evolving,scenarios controlled ...
... that it was easy to quit smoking because he did it ... why some people find it so difficult to stop smoking even ... statistics provided by the Centers for Disease Control and Prevention (CDC), ... United States, and it is the second major cause of death ...
... features include remote printing, real-time medical necessity checking, ... for draw-station future orders., MENLO PARK, Calif., ... applications for healthcare and integration software,solutions, today announced ... Blue Iris eLaborate provides a flexible, easy-to-use, web-based ...
... Synova Healthcare Group,Inc. (OTC Bulletin Board: SNVH), today ... in aggregate notional principal amount of its,6.5% senior convertible ... common stock purchase warrants. This sale was effected as ... and warrants in the,aggregate notional principal amount of up ...
... NEW YORK Repeated courses of a drug that ... babies also may increase the risk of cerebral palsy ... study, funded by the National Institutes of Health and ... gynecology, Columbia University Medical Center and attending obstetrician and ...
... to female sex-change surgery are happy with the results, despite ... of over 200 patients in the September issue of the ... the Departments of Urology and Psychiatry at University Hospitals of ... patients who had undergone surgery and 70 who took part ...
Cached Medicine News:Health News:Mecklenburg EMS Introduces Most-Advanced Situational Training in America for Emergency Medical Personnel 2Health News:Genetic variation affects smoking cessation treatment 2Health News:MITEM Releases Blue Iris eLaborate 8.6 2Health News:Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants 2Health News:Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants 3Health News:Repeat steroids to premature infants linked to cerebral palsy 2Health News:Most patients who have male-to-female sex-change surgery are happy, despite complications 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... report is available in its catalogue: ... and Technologies for Advanced Drug Delivery ... Administration http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
(Date:1/15/2014)...  A novel wearable injector slightly larger than an Oreo cookie ... self-inject prescription drugs in the large doses required to treat ... deficiencies, and genetic disorders.  An emerging biologic ... according to analysts.   Many of these drugs will require a ...
(Date:1/14/2014)...  Luminex Corporation (Nasdaq: LMNX ) today announced that ... 2013 on Monday, February 3, 2014. A press release announcing ... trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... highlights and financial results for the fourth quarter and twelve ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
... WIRE via COMTEX News Network),-- Endo Pharmaceuticals ... Holdings Inc. (NASDAQ: ENDP), has presented results,from ... evaluating Frova (frovatriptan succinate) 2.5 mg,tablets as ... menstrual migraine (MM). The data demonstrated,that FROVA ...
... SALT LAKE CITY, UT, June 11, 2007 ... Genetics, Inc. (NASDAQ: MYGN) (<a target=,"_blank" href="http://www.myriad.com/">www.myriad.com ... comparison of a,"Staggered Start" and a "Randomized ... Staggered Start" clinical trial,design at the Alzheimer's ...
Cached Medicine Technology:Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 2Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 3Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 4Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 5Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 7Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 2Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 3Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 4Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 5
Phaco-emulsification systems CV series...
The unprecedented power, flexibility and versatility of the Series 20000 Legacy have made it the world's leading phacoemulsifier....
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings....
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings....
Medicine Products: